Company / AR per Share
Ligand Pharmaceuticals, Inc. AR per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
$3.12
FY2025
5-year range
$1.81 / $5.31
FY2021-FY2025
Trend
+42.7%
vs FY2024
Sector context
#32 of 113
Health Care
What the data says
At $3.12, Ligand Pharmaceuticals, Inc.'s ar per share ranks #32 of 113 in the Health Care sector. AR per Share has increased for 3 consecutive years, from $1.81 in FY2022 to $3.12 in FY2025.
Based on SEC 10-K filings.
3.12 in FY2025 with a 5-year CAGR of -1.6%.
Improved from $1.94 to $3.12 over the past 2 years.
Health Care sector context is included.
AR per Share over time
Growth rates
- 3-Year CAGR
- +19.8%
- 5-Year CAGR
- -1.6%
- 10-Year CAGR
- -
Sector benchmark
#32 of 113 in Health CareTop 28% of 113This company $3.12 Sector average $28.83
▼
-89.2% below sector average
Key checks
Key Insights
- Ligand Pharmaceuticals, Inc.'s ar per share has grown for 3 consecutive years.
- In FY2025, ar per share increased 42.7% year-over-year.
- Ranks #32 out of 113 companies in the Health Care sector.
- Peak ar per share was recorded in FY2021.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.12 | +42.7% |
| FY2024 | $2.19 | +12.6% |
| FY2023 | $1.94 | +7.0% |
| FY2022 | $1.81 | -65.9% |
| FY2021 | $5.31 | +57.3% |
| FY2020 | $3.38 | +130.9% |
| FY2019 | $1.46 | -44.6% |
| FY2018 | $2.64 | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026